Two conferences were held in Hanoi and Ho Chi Minh City in early March to discuss shingles in comorbid patients.

La empresa busca mpulsar el crecimiento en sectores clave como salud, retail y comercio electrónico. Colombia es un mercado ...

Expertos explican cómo se transmite la bacteria Neisseria meningitidis y por qué la letalidad en niños y adultos es tan preocupante. Cómo prevenir su contagio y razones para vacunarse.

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Esto significa que los dueños de las patentes (la farmacéutica ViiV Healthcare (ViiV), cuyos dueños son Pfizer, GlaxoSmithKline (GSK) y Shionogi), perdían el derecho exclusivo de comercializar ...

Por su parte, Fajardo explica que en Colombia circulan cinco tipos diferentes de meningococos ... Explica que ese alto costo también se debe a que, a la fecha, un solo laboratorio, en este caso GSK, ...

Nombre local: TIVICAY 25 mg Tab. recubierta País: Colombia Laboratorio: GLAXOSMITHKLINE COLOMBIA S.A. Registro sanitario: INVIMA 2023M-0021052 Vía: oral Forma: comprimido recubierto ATC: DOLUTEGRAVIR ...

Nombre local: CELSENTRI 150 mg Tab. recubierta País: Colombia Laboratorio: GLAXOSMITHKLINE COLOMBIA S.A. Registro sanitario: INVIMA 2008M-0008014 Vía: oral Forma: comprimido recubierto ATC: MARAVIROC ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...